A Comparative Study on the Efficacy of AI Temperature-controlled Radiofrequency Technology and Electrical Stimulation in the Treatment of Vulvar Leukoplakia
- Conditions
- Vulvar Lichen Sclerosus
- Interventions
- Procedure: Radiofrequency technologyProcedure: Electrical stimulation
- Registration Number
- NCT05250466
- Lead Sponsor
- Zhongnan Hospital
- Brief Summary
The study was designed as a prospective, multicenter, randomized, open-label, parallel-controlled clinical trial. The study population was patients with vulvar leukoplakia, and compared the efficacy and safety of AI temperature-controlled radio frequency technology and electrical stimulation in the treatment of vulvar leukoplakia. According to the research purpose, the sample size was calculated and determined to be 120 cases, and they were randomly assigned to the observation group and the control group according to the ratio of 1:1, namely 60 cases in the radio frequency observation group and 60 cases in the electric stimulation control group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 120
- Diagnosed by pathological examination, meeting the diagnostic criteria for leukoplakia;
- 18 to 60 years old;
- Agree to sign the informed consent;
- Patients with severe liver and kidney dysfunction;
- Combined with HIV, syphilis infection, acute vaginitis, cervical cancer;
- Patients with cardiovascular disease;
- People with hematological diseases;
- Patients with hypertension and diabetes;
- People with mental illness;
- Pregnant and lactating women.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Radiofrequency group Radiofrequency technology AI Temperature-controlled Radiofrequency Technology Electrical stimulation group Electrical stimulation Electrical Stimulation
- Primary Outcome Measures
Name Time Method Efficacy index 6 month after treatment Efficacy index: (score before treatment-score after treatment)/(score before treatment)×100%
- Secondary Outcome Measures
Name Time Method Recurrence rate 6 month after treatment Percentage of recurrence of genital itching 6 months after treatment
Trial Locations
- Locations (1)
Zhongnan Hospital of Wuhan University
🇨🇳Wuhan, Hubei, China